有研究发现，Coats病患者眼内血管内皮生长因子(vascular e

Studies have found that the concentration of vascular endothelial growth factor (VEGF) in the eyes of patients with Coats disease is high. The use of anti-VEGF drugs can effectively reduce the expression level of VEGF. At the same time, it can reduce neovascularization on the surface of the retina, thereby promoting The absorption of fluid is of great benefit to the treatment of Coats disease, especially the early Coats disease, which greatly reduces the possibility of eyeball removal

Studies have found that the high concentration of vascular endothelial growth factor (VEGF) in Coats patients, the use of anti-VEGF drugs can effectively reduce the expression level of VEGF, at the same time, can reduce the surface of the retina newborn blood vessels, thereby promoting the absorption of sub-retinal fluid, the treatment of Coats disease is of great benefit, especially the early Coats disease, greatly reduce sepsis of the possibility of eye removal.

Some studies have found that the vascular endothelial growth factor (VEGF) in the eyes of Coats disease patients was significantly higher than that in the control group Factor, VEGF) concentration is high, the use of anti VEGF drugs can effectively reduce the expression level of VEGF, at the same time, it can reduce the retinal surface neovascularization, thus promoting the absorption of subretinal fluid, which is of great benefit to the treatment of Coats disease, especially the early Coats disease, which greatly reduces the possibility of enucleation<br>